MedPath

NET for SGBV Survivors in Eastern DR Congo

Not Applicable
Completed
Conditions
Posttraumatic Stress Disorder
Shame
Interventions
Behavioral: Narrative Exposure Therapy
Behavioral: Social Support
Registration Number
NCT02989987
Lead Sponsor
University of Konstanz
Brief Summary

Throughout the last 10 years Narrative Exposure Therapy (NET) has evolved as one of the most effective, culturally sensitive trauma interventions. In the present study the effectiveness of NET delivered by trained health personnel in a sample of survivors of sexual and gender based violence (SGBV) who suffer from Posttraumatic Stress Disorder (PTSD) will be assessed. Structured baseline, 3 and 6 month follow up interviews will be administered to assess the main outcome measures PTSD and shame. The trial will take place in Goma, DR Congo, where SGBV and its sequelae has been a major problem.

Detailed Description

Participants will be recruited through local NGOs and eligible clients randomized to the treatment (NET; app. N=100) or treatment-as-usual control (app. N=100) group, respectively. At baseline, 3-month and 6-month post-treatment, sociodemographic data, trauma exposure - esp. SGBV, PTSD, dissociation, shame, functionality and depression will be assessed in a structured interview. The interviews will be conducted by blind Congolese psychological interviewers after an intensive 3-weeks training and continuous supervision.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
201
Inclusion Criteria
  • SGBV survivors (event happened more than 4 weeks ago)
  • PTSD diagnosis (DSM-5)
Exclusion Criteria
  • Acute psychosis
  • Signs of cerebro-organic disease
  • Acute drug or alcohol intoxication

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Narrative Exposure TherapyNarrative Exposure TherapyAccording to the NET manual (one lifeline session and 7 exposure sessions; see Schauer et al. 2011).
Treatment-as-usualSocial SupportSocial support (provided on demand)
Primary Outcome Measures
NameTimeMethod
SVQ: Severity of shame (sumscore)Change from baseline to 3 and 6 months post treatment

Shame Variability Questionnaire (Brown, Rizvi \& Linehan, unpublished)

PSS-I: Posttraumatic Stress Disorder symptom severity (sumscore and diagnosis)Change from baseline to 3 and 6 months post treatment

PTSD Symptom Scale - Interview (PSS-I; Foa \& Tolin, 2000)

Secondary Outcome Measures
NameTimeMethod
PHQ: Depression symptom severity (sumscore)Change in 3 and 6 months post treatment

Patient Health Questionnaire - 9 (PHQ-9; Kroenke \& Spitzer, 2002)

Functionality (sumscore)3 and 6 months post treatment

Local Functionality Index (LFI; Bass et al., 2013)

ShutD: Severity of Shutdown Dissociation Symptoms (sumscore)Change from baseline to 3 and 6 months post treatment

Shutdown Dissociation Scale (Schalinski et al., 2015)

Trial Locations

Locations (1)

University of Konstanz

🇩🇪

Konstanz, BW, Germany

© Copyright 2025. All Rights Reserved by MedPath